Clinical Trial Update: Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome [Phase 2]

View source ↗

Summary

This clinical trial update reports that a Phase 2 study evaluating montelukast for obstructive sleep apnea in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

Sponsor: University of Louisville | Conditions: Sleep Apnea | Phase 2 | Status: WITHDRAWN